Engager Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $410K

  • Investors
  • 1

Engager Bio General Information

Description

Developer of cancer immunotherapies designed to target and eliminate tumor cells through gamma delta T-cell-based treatments. The company develops next-generation oncology therapeutics aimed at improving the effectiveness of cancer treatment while maintaining a favorable safety profile, enabling healthcare providers to address a range of malignant diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Amsterdam
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Engager Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2026 $410K Completed Startup
To view Engager Bio’s complete valuation and funding history, request access »

Engager Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovatiefonds Noord-Holland Venture Capital Minority
To view Engager Bio’s complete investors history, request access »

Engager Bio FAQs

  • When was Engager Bio founded?

    Engager Bio was founded in 2025.

  • Where is Engager Bio headquartered?

    Engager Bio is headquartered in Amsterdam, Netherlands.

  • What industry is Engager Bio in?

    Engager Bio’s primary industry is Drug Discovery.

  • Is Engager Bio a private or public company?

    Engager Bio is a Private company.

  • What is Engager Bio’s current revenue?

    The current revenue for Engager Bio is .

  • How much funding has Engager Bio raised over time?

    Engager Bio has raised $410K.

  • Who are Engager Bio’s investors?

    Innovatiefonds Noord-Holland has invested in Engager Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process